KENILWORTH, New Jersey – The U.S. Food and Drug Administration has approved a vaccine for children that guards against multiple
The single shot vaccine is a combination “diphtheria-tetanus-pertussis-hepatitis B-poliomyelitis-invasive haemophilus influenza type B disease” vaccine.
Vaxelis is designed for children aged 6 weeks to 4 years old.
Sanofi and Merck are now working on the production and supply of Vaxelis.
The company reports it won’t be available in the U.S. before 2020.
A press release from Sanofi details more about how the vaccine would work.